The latest news on transcatheter mitral and tricuspid therapies
TMTT Today Special Edition
Explore the 12 reasons to adopt the PASCAL repair system
TMTT Today #8 - September 2022
PASCAL Platform showing unparalleled TR outcomes
Read more to discover the latest evidence on tricuspid therapies and experts' suggestions for the selection of PASCAL implants to treat MR
DownloadTMTT Today #7 – February 2022
PASCAL Platform: Bringing you predictable and sustained MR reduction
Read more about the predictability of the PASCAL repair system in minimising residual MR, the latest data from clinical and real-world studies, and much more!
Short video summary
TMTT Today #6 – October 2021
Discover the latest evidence on tricuspid regurgitation
Learn about the most current evidence and real-world experience on Edwards Lifesciences' portfolio of therapies for tricuspid regurgitation
Short video summary
TMTT Today #5 – May 2021
Stability, control and procedural confidence with the new PASCAL Stabilizer Rail System
Discover the new PASCAL Stabilizer Rail System, the latest advancements in treating TR, and PASCAL real-world data on both MR and TR
DownloadTMTT Today #4 - April 2021
Getting up to speed with the PASCAL Platform
Make the most of the PASCAL platform to deliver optimal outcomes for your MR and TR patients
Short video summary
TMTT Today #3 - December 2020
The PASCAL Platform. A complete solution for transcatheter mitral and tricuspid valve repair
Reporting the PASCAL platform impressive outcomes in mitral and tricuspid valve repair.
Download
TMTT Today #2 - October 2020
New advances in the transcatheter mitral and tricuspid valve repair portfolio | PASCAL Repair System
Presenting the recently published CLASP study 1-year follow-up as well as the early experiences of the PASCAL repair system in patients with tricuspid regurgitation.
Download
TMTT Today #1 - July 2020
Explore the Edwards PASCAL Transcatheter Valve Repair System
Spotlighting the real world evidence from 1200 patients with mitral regurgitation, who received the PASCAL repair system and the 30-day outcomes from the CLASP study.
DownloadSign up now
and stay up-to-date with mitral and tricuspid therapies
Sign up now to receive event and news information from Edwards Lifesciences including:
- Publications
- Congress highlights
- Webinar invites
- Product announcements and updates
Edwards Lifesciences welcomes you!Thank you for registering to receive information from Edwards Lifesciences. |
Learn more about Edwards Lifesciences’ transcatheter mitral and tricuspid product portfolio
TMTT, transcatheter mitral and tricuspid therapies.